Siemens and Sana Kliniken team up on AI tools

Published on 19/11/2026 • By Endah Wijaya • Health Policy
Siemens and Sana Kliniken team up on AI tools - ai healthcare tools
The agreement allows Siemens Healthineers to train AI algorithms using curated German healthcare datasets, including clinical records, medical images, and radiology reports.

Siemens Healthineers and Sana Kliniken have launched a collaboration to develop and test AI-powered healthcare tools in Germany, with an initial focus on lung cancer screening. The partnership combines Siemens Healthineers’ medical technology expertise with Sana Kliniken’s access to anonymized patient data through its subsidiary, Sana Data Solutions GmbH.

The agreement allows Siemens Healthineers to train AI algorithms using curated German healthcare datasets, including clinical records, medical images, and radiology reports. These datasets will be processed in a secure, controlled environment to ensure compliance with data protection laws. The goal is to accelerate the development of software solutions that improve diagnostics, treatment planning, and personalized care pathways.

Stefan Schaller, Head of Central and Western Europe at Siemens Healthineers, emphasized that the partnership provides a structured approach to innovation while maintaining responsible data use. For Sana Kliniken, the collaboration offers a way to apply advanced analytics to complex medical data, turning research into practical healthcare applications.

One key challenge in European healthcare AI development is access to high-quality, locally sourced clinical data. Many AI models currently rely on datasets from outside Europe, which may not reflect regional patient populations or regulatory standards. This partnership aims to address that gap by creating a German-based testing environment where AI tools can be validated in real-world clinical settings.

Sana Kliniken’s affiliated radiology facilities will supply anonymized lung cancer screening data, including pathological information, diagnostic results, and examination sequences. The partners plan to expand the dataset over time to include additional patient context. Security measures will be implemented to protect sensitive information and meet privacy requirements.

After development, the AI software will be evaluated in routine clinical workflows across Sana Kliniken’s hospitals and radiology practices. This testing phase will help assess performance in everyday settings and identify opportunities to refine diagnostic processes and treatment recommendations.

Beyond lung cancer, the partnership could extend to other areas of diagnostics and personalized medicine. The initiative aligns with broader efforts in Europe to strengthen data sovereignty and develop AI solutions that meet regional regulatory needs. For medical technology companies, access to representative clinical datasets is critical for validating AI applications before broader adoption.

You may also like

Leave a Comment

Your email address will not be published. Required fields are marked *